Evidence map›Paper›PMID 26239953›Full record

ArticleScientific reports2015

Real-Time MRI-Guided Catheter Tracking Using Hyperpolarized Silicon Particles.

Nicholas Whiting, Jingzhe Hu, Jay V Shah, Maja C Cassidy, Erik Cressman, Niki Zacharias Millward, David G Menter, Charles M Marcus, Pratip K Bhattacharya

Abstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Post-Acquisition HyperpolarizedDiagnostics (Basel, Switzerland) · 2022
    Article
  4. Article
  5. Hyperpolarized MRI with silicon micro and nanoparticles: Principles and applications.Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2021
    Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Nicholas WhitingDepartment of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Jingzhe Hu1] Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 [2] Department of Bioengineering, Rice University, Houston, TX 77030.
Jay V Shah1] Department of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 [2] Department of Biomedical Engineering, The University of Texas at Austin, Austin, TX 78712.
Maja C CassidyKavli Institute of NanoScience, Delft University of Technology, Delft, Netherlands.
Erik CressmanDepartment of Interventional Radiology, The University of Texas MD Anderson Cancer Center, Houston TX 77030.
Niki Zacharias MillwardDepartment of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
David G MenterDepartment of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston TX, 77030.
Charles M MarcusNiels Bohr Institute, University of Copenhagen, Denmark.
Pratip K BhattacharyaDepartment of Cancer Systems Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Scott Kopetz · 1985 to 2026
$290.8M
R25 SUPPLEMENT IN GENETIC EPIDEMIOLOGY EDUCATIONR25CA057730 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI CHANG, SHINE · 1992 to 2016
$18.6M
Texas Center for Cancer NanomedicineU54CA151668 · NCI · UNIVERSITY OF TEXAS HLTH SCI CTR HOUSTON · PI FERRARI, MAURO · 2010 to 2014
$12.4M
(PQC5)Early Detection Pancreatic Cancer by Hyperpolarized Silicon NanoparticlesR21CA185536 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI BHATTACHARYA, PRATIP K. · 2014 to 2015
$383k
NCI NIH HHS CA016672NCI NIH HHS P30 CA016672NCI NIH HHS R21 CA185536NCI NIH HHS R25 CA057730NCI NIH HHS R25T CA057730NCI NIH HHS U54 CA151668NCI NIH HHS U54CA151668-03
6 · The paper itself

Abstract

Visualizing the movement of angiocatheters during endovascular interventions is typically accomplished using x-ray fluoroscopy. There are many potential advantages to developing magnetic resonance imaging-based approaches that will allow three-dimensional imaging of the tissue/vasculature interface while monitoring other physiologically-relevant criteria, without exposing the patient or clinician team to ionizing radiation. Here we introduce a proof-of-concept development of a magnetic resonance imaging-guided catheter tracking method that utilizes hyperpolarized silicon particles. The increased signal of the silicon particles is generated via low-temperature, solid-state dynamic nuclear polarization, and the particles retain their enhanced signal for ≥ 40 minutes--allowing imaging experiments over extended time durations. The particles are affixed to the tip of standard medical-grade catheters and are used to track passage under set distal and temporal points in phantoms and live mouse models. With continued development, this method has the potential to supplement x-ray fluoroscopy and other MRI-guided catheter tracking methods as a zero-background, positive contrast agent that does not require ionizing radiation.

Indexed as

AnimalsContrast MediaFluoroscopyHumansMagnetic Resonance ImagingMaleMiceMice, TransgenicPhantoms, ImagingSiliconTime FactorsUrinary CathetersVascular Access DevicesContrast MediaSilicon

Identifiers

PMID26239953
PMCPMC4523869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.